Skip to main content

Table 4 Surgical interventions and morbidity

From: Surgical resection and outcome of pancreatic cystic neoplasms in China: analysis of a 16-year experience from a single high-volume academic institution

 

IPMN (n = 17)

MCN (n = 20)

SCN (n = 39)

SPN (n = 35)

Types of resection, n (%)

    

Distal pancreatectomy, splenectomy

2 (11.8%)

11 (55%)

11 (28.2%)

12 (34.3%)

Spleen-preserving distal pancreatectomy

2 (11.8%)

6 (30%)

3 (7.7%)

3 (8.6%)

Pancreaticoduodenectomy

11 (64.7%)

 

6 (15.4%)

9 (25.7%)

Pylorus-preserving pancreaticoduodenectomy

  

1 (2.6%)

 

Middle pancreatectomy

  

12 (30.8%)

5 (14.3%)

Tumor enucleation

1 (5.9%)

2 (10%)

6 (15.4%)

6 (17.1%)

Laparotomy with biopsy

 

1 (5%)

  

Total pancreatectomy

1 (5.9%)

   

Postoperative complications, n (%)

8 (47.1%)

6 (30%)

15 (38.5%)

21 (60%)

No complications, n (%)

9 (52.9%)

14 (70%)

24 (61.5%)

14 (40%)

Re-operation (n)

0

0

2 (5.1%)

2 (5.7%)

Hospital stay after surgery, days, median (range)

19.0 (12.0-74.0)

13.0 (8.0-26.0)

20.0 (7.0-123.0)

16.0 (7.0-99.0)